Literature DB >> 16516835

An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival.

Wentian Yang1, Lori D Klaman, Binbin Chen, Toshiyuki Araki, Hisashi Harada, Sheila M Thomas, Elizabeth L George, Benjamin G Neel.   

Abstract

Little is known about how growth factors control tissue stem cell survival and proliferation. We analyzed mice with a null mutation of Shp2 (Ptpn11), a key component of receptor tyrosine kinase signaling. Null embryos die peri-implantation, much earlier than mice that express an Shp2 truncation. Shp2 null blastocysts initially develop normally, but they subsequently exhibit inner cell mass death, diminished numbers of trophoblast giant cells, and failure to yield trophoblast stem (TS) cell lines. Molecular markers reveal that the trophoblast lineage, which requires fibroblast growth factor-4 (FGF4), is specified but fails to expand normally. Moreover, deletion of Shp2 in TS cells causes rapid apoptosis. We show that Shp2 is required for FGF4-evoked activation of the Src/Ras/Erk pathway that culminates in phosphorylation and destabilization of the proapoptotic protein Bim. Bim depletion substantially blocks apoptosis and significantly restores Shp2 null TS cell proliferation, thereby establishing a key mechanism by which FGF4 controls stem cell survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516835     DOI: 10.1016/j.devcel.2006.01.002

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  104 in total

1.  G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

Authors:  Muneyoshi Futami; Quan-Sheng Zhu; Zakary L Whichard; Ling Xia; Yuehai Ke; Benjamin G Neel; Gen-Sheng Feng; Seth J Corey
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Regulation of kidney development by Shp2: an unbiased stereological analysis.

Authors:  Frank S David; Luise Cullen-McEwen; Xue Sue Wu; Stephen R Zins; Julie Lin; John F Bertram; Benjamin G Neel
Journal:  Anat Rec (Hoboken)       Date:  2010-08-23       Impact factor: 2.064

3.  SHP-2 acts via ROCK to regulate the cardiac actin cytoskeleton.

Authors:  Yvette Langdon; Panna Tandon; Erika Paden; Jennifer Duddy; Joan M Taylor; Frank L Conlon
Journal:  Development       Date:  2012-01-25       Impact factor: 6.868

4.  Structure-based kinetic models of modular signaling protein function: focus on Shp2.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

5.  Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1.

Authors:  Shenaz Khan; Sujata Lakhe-Reddy; Joseph H McCarty; Christine M Sorenson; Nader Sheibani; Louis F Reichardt; Jane H Kim; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

6.  Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL.

Authors:  Yuan Ren; Zhengming Chen; Liwei Chen; Nicholas T Woods; Gary W Reuther; Jin Q Cheng; Hong-gang Wang; Jie Wu
Journal:  J Biol Chem       Date:  2007-10-17       Impact factor: 5.157

Review 7.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

8.  SHP-2 tyrosine phosphatase in human diseases.

Authors:  Hong Zheng; Shawn Alter; Cheng-Kui Qu
Journal:  Int J Clin Exp Med       Date:  2009-01-30

9.  Shp2-dependent ERK signaling is essential for induction of Bergmann glia and foliation of the cerebellum.

Authors:  Kairong Li; Alan W Leung; Qiuxia Guo; Wentian Yang; James Y H Li
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  Shp2/MAPK signaling controls goblet/paneth cell fate decisions in the intestine.

Authors:  Julian Heuberger; Frauke Kosel; Jingjing Qi; Katja S Grossmann; Klaus Rajewsky; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.